• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有阈值效应的化学品的安全性评估。

Safety assessments of chemicals with thresholded effects.

作者信息

Lu F C

出版信息

Regul Toxicol Pharmacol. 1985 Dec;5(4):460-4. doi: 10.1016/0273-2300(85)90009-1.

DOI:10.1016/0273-2300(85)90009-1
PMID:4095286
Abstract

Toxicological evaluation of chemicals with thresholded effects involves the estimation of their acceptable daily intakes (ADI). The following steps are involved in the evaluation: judging the completeness of the available chemical and biological data, determination of the no-effect level (NEL), selection of an appropriate safety factor, and extrapolation of the NEL to the ADI using the selected safety factor. The relative insignificance of the sample size on the NEL, the advantages of body weight (compared to the body surface) as a basis for interspecies extrapolation, the size of the safety factor as a function of the nature of the toxic effects, and the multiplicity of the toxicological investigations, in addition to the conventional short-term and long-term toxicity studies, are described. In addition, the possible inadvisability of overemphasizing the importance of dose-response relationship at the expense of in-depth, relevant studies is discussed.

摘要

对具有阈值效应的化学品进行毒理学评估涉及估计其每日允许摄入量(ADI)。评估包括以下步骤:判断现有化学和生物学数据的完整性、确定无效应水平(NEL)、选择合适的安全系数,以及使用选定的安全系数将NEL外推至ADI。文中描述了样本量对NEL的相对不重要性、作为种间外推基础的体重(与体表面积相比)的优势、安全系数大小与毒性效应性质的函数关系,以及除传统的短期和长期毒性研究外毒理学研究的多样性。此外,还讨论了以深入、相关研究为代价过度强调剂量-反应关系重要性可能带来的不可取性。

相似文献

1
Safety assessments of chemicals with thresholded effects.具有阈值效应的化学品的安全性评估。
Regul Toxicol Pharmacol. 1985 Dec;5(4):460-4. doi: 10.1016/0273-2300(85)90009-1.
2
Precision of estimates of an ADI (or TDI or PTWI).每日允许摄入量(或暂定每日摄入量或每日耐受摄入量)估计值的精确度。
Regul Toxicol Pharmacol. 1999 Oct;30(2 Pt 2):S87-93. doi: 10.1006/rtph.1999.1331.
3
Background to the ADI/TDI/PTWI.每日允许摄入量/暂定每日允许摄入量/每日耐受摄入量的背景知识。
Regul Toxicol Pharmacol. 1999 Oct;30(2 Pt 2):S109-13. doi: 10.1006/rtph.1999.1335.
4
Assessment of safety/risk of chemicals: inception and evolution of the ADI and dose-response modeling procedures.
Toxicol Lett. 1991 Dec;59(1-3):5-40. doi: 10.1016/0378-4274(91)90052-8.
5
Deriving allowable daily intakes for systemic toxicants lacking chronic toxicity data.推导缺乏慢性毒性数据的全身毒性物质的每日允许摄入量。
Regul Toxicol Pharmacol. 1987 Mar;7(1):96-112. doi: 10.1016/0273-2300(87)90050-x.
6
Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.用于确定化学品安全性的风险评估原则:药物中残留溶剂及邻苯二甲酸二(2-乙基己基)酯的近期评估
Congenit Anom (Kyoto). 2004 Jun;44(2):51-9. doi: 10.1111/j.1741-4520.2004.00009.x.
7
The no-effect level and optimal use of toxicity data.毒性数据的无效应水平及最佳应用
Regul Toxicol Pharmacol. 1988 Dec;8(4):385-8. doi: 10.1016/0273-2300(88)90036-0.
8
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.转基因植物及其衍生食品和饲料的安全性与营养评估:动物饲养试验的作用
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13.
9
Report of workshop on the significance of excursions of intake above the ADI.关于摄入量超过每日允许摄入量(ADI)的偏差的重要性研讨会报告。
Regul Toxicol Pharmacol. 1999 Oct;30(2 Pt 2):S2-12. doi: 10.1006/rtph.1999.1319.
10
An analysis of the risk of exceeding the acceptable or tolerable daily intake.对超过可接受或可耐受每日摄入量风险的分析。
Regul Toxicol Pharmacol. 1993 Dec;18(3):463-80. doi: 10.1006/rtph.1993.1071.

引用本文的文献

1
Integrated network pharmacology and transcriptomics to explore the mechanism of compound Dihuang granule (CDG) protects dopaminergic neurons by regulating the Nrf2/HMOX1 pathway in the 6-OHDA/MPP-induced model of Parkinson's disease.综合网络药理学和转录组学以探究复方地黄颗粒(CDG)在6-羟基多巴胺/1-甲基-4-苯基吡啶离子诱导的帕金森病模型中通过调节Nrf2/HMOX1通路保护多巴胺能神经元的机制。
Chin Med. 2024 Dec 18;19(1):170. doi: 10.1186/s13020-024-01040-7.